| 229.22 -11.93 (-4.95%) | 04-19 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 292.79 | 1-year : | 341.98 |
| Resists | First : | 250.67 | Second : | 292.79 |
| Pivot price | 226.2  |
|||
| Supports | First : | 210.17 | Second : | 185.13 |
| MAs | MA(5) : | 231.72 |
MA(20) : | 221.61 |
| MA(100) : | 195.33 |
MA(250) : | 222.77 |
|
| MACD | MACD : | 9.3 |
Signal : | 8.9 |
| %K %D | K(14,3) : | 74.7 |
D(3) : | 68.5 |
| RSI | RSI(14): 56.5 |
|||
| 52-week | High : | 330 | Low : | 123.26 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ INSP ] has closed below upper band by 43.6%. Bollinger Bands are 17.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 245.12 - 246.51 | 246.51 - 248.03 |
| Low: | 224.67 - 226.14 | 226.14 - 227.74 |
| Close: | 226.45 - 229 | 229 - 231.78 |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Fri, 19 Apr 2024
RBC Capital starts Inspire Medical at outperform, cites first-mover status (NYSE:INSP) - Seeking Alpha
Fri, 19 Apr 2024
Inspire Medical Systems (NYSE:INSP) Coverage Initiated by Analysts at Royal Bank of Canada - MarketBeat
Fri, 19 Apr 2024
Federated Hermes Inc. Has $92.21 Million Stock Holdings in Inspire Medical Systems, Inc. (NYSE:INSP) - MarketBeat
Fri, 19 Apr 2024
The Latest Analyst Ratings For Inspire Medical Systems - Inspire Medical Systems (NYSE:INSP) - Benzinga
Fri, 19 Apr 2024
Inspire medical systems CFO sells $3.45 million in company stock - Investing.com
Thu, 18 Apr 2024
Why You Should Add Inspire Medical (INSP) to Your Portfolio - Zacks Investment Research
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 30 (M) |
| Shares Float | 29 (M) |
| Held by Insiders | 1.9 (%) |
| Held by Institutions | 104.2 (%) |
| Shares Short | 2,080 (K) |
| Shares Short P.Month | 1,750 (K) |
| EPS | -0.73 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.37 |
| Profit Margin | -3.4 % |
| Operating Margin | 4.8 % |
| Return on Assets (ttm) | -4.1 % |
| Return on Equity (ttm) | -4 % |
| Qtrly Rev. Growth | 39.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 20.62 |
| EBITDA (p.s.) | -1.24 |
| Qtrly Earnings Growth | 368.2 % |
| Operating Cash Flow | 25 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -318.37 |
| PEG Ratio | -11.7 |
| Price to Book value | 11.83 |
| Price to Sales | 11.11 |
| Price to Cash Flow | 281.75 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|